Funding Neuro has supported Professor Steven Gill over a number of years in his ground breaking treatments for DIPG using Convection Enhanced Delivery methods. During this time18 children have been treated under compassionate treatment with MHRA (‘Medical and Healthcare products Regulatory Agency’) approval and an academic paper on 13 patients was published in the International Journal of Clinical Oncology in January 2021. The conclusions drawn in the paper were that the CED system used was safe and that the drug treatment slowed down the cancer by c.50%. An amazing result!
Unfortunately Renishaw plc, the owners of the CED device used in this treatment have stated that they are unwilling to provide free use of the CED device rendering a full clinical trial uneconomic at this time.
Funding Neuro remains supportive of Professor Gill’s work in this area and are exploring all options.
